Join us for a Grassroots Reception at Nexus 2021; Expanding Access to COVID-19 Therapeutics –HHS PREP Act Declaration: Ninth Amendment; HHS Comprehensive Plan for Addressing High Drug Prices; AMCP Virtual Legislative Days 2021; ICYMI: Respond to AMCP Policy Action Items Survey; AMCP Urges Congress to Implement Continuous Eligibility for Children in Medicaid and CHIP.
AMCP Urges HHS to Extend Medicare Part D Enhanced MTM Mode; Biden Administration Withdraws the Most Favored Nations Model; AMCP Supports FDA Approval of Biosimilar Insulin; President Biden Calls on Congress to Reduce Drug Prices.
AMCP Submits Comments on OMB Equity RFI; President Biden Signs Executive Order on Increasing Competition; CMS Opens National Coverage Determination Process for Aduhelm; Congress Releases 21st Century Cures 2.0 Discussion Draft.
AMCP-Legislative-Regulatory-Briefing-June-2021; AMCP Submits Comments on Proposed Part D MTM Program CMR Changes; Medicaid Drug Rebate Program Best Price Rule Delayed; 2021 Federal and State Legislative and Regulatory Update Available on AMCP Learn; AMCP Statement of Support for CMS Administrator Brooks-LaSure.
House Energy and Commerce Subcommittee Holds Hearing on Drug Pricing Legislation; AMCP Issues Statement Congratulating HHS Deputy Secretary Palm; AMCP Sends Letter to Senate Finance Committee in Support of Chiquita Brooks-Lasure.
President Biden Signs American Rescue Plan Act; Become a State Advocacy Leader; Students’ Role in Grassroots Advocacy; AMCP Signs Medicaid Stakeholder Letter to Congressional Leaders.